A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia
Clinical trial NCT06211634 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06211634
- Sponsor
- Hemab ApS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-13
- Primary completion
- 2027-08-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.